International Alliance for PharmacoGenetic Epidemiology Excellence (iAPOGEE)

The purpose of the iAPOGEE consortium is to enhance collaboration within education and research in pharmaco- and genetic epidemiology between the partner universities and institutions.

Image may contain: Font, Material property, Circle, Graphics, Illustration.

A summary of the work packages included in the iAPOGEE consortium, including observational studies (WP1), methods development (WP2), and genetics and teratology (WP3).

By doing so, iAPOGEE will unite researchers who together will be able to move beyond conventional pharmacoepidemiological studies by combining novel, state-of-the-art molecular, quantitative genetic, and causal inference methods with computational resources and clinical expertise, to improve our knowledge about effect and safety of pharmaceuticals in humans in the near future.

We believe that innovation and scientific renewal will emerge through a strong focus on interdisciplinary teamwork, career development, creating an inspiring learning environment, and international leadership. Establishment of the iAPOGEE initiative in collaboration with two world-leading program in epidemiology and biostatistics at McGill and University of Bordeaux, one leading training program in teratology in the US, and two upcoming research environments in in clinical genetics South Africa and Brazil, is in line with this vision.

Funding

Funding was obtained through the NFR International Partnerships for Excellent Education and Research (INTPART). According to the NFR, "The objective of the INTPART programme is to develop world-class research and education in Norway. The programme will create a framework for expanding cooperation between research groups considered to be at the international forefront today or that are believed to have the potential to become world leaders in their fields in the future." Main collaborators are presented below. Activities include workshops, research, and student mobility, training, course development, and conferences.​

Published June 21, 2021 11:31 AM - Last modified Sep. 1, 2021 4:20 PM

Contact

Leader team

Professor
Hedvig Nordeng

(Department of Pharmacy)

Professor
Eivind Ystrøm

(Department of Psychology)

Professor 
Geir Kjetil Sandve 

(Department of Informatics)

Senior researcher
Kristina Gervin

(Division of Clinical Neuroscience, Oslo University Hospital)

Professor
Sven Ove Samuelsen
(Department of Mathematics)

External partners

Professor
Antoine Pariente
(Team Pharmacoepidemiology, Inserm U1219 Research Center Bordeaux Population Health, University of Bordeaux, France)

Professor
Christina Chambers
(Center for Better Beginnings, University of California, USA)

Professor
Laura Yates
(KwaZulu-Natal Research, Innovation and Sequencing Platform (KRISP), University of KwaZulu-Natal, South Africa)

Professor
Lavinia Schuler-Faccini
(Genetics Department, Biosciences Institute, Federal University of Rio Grande do Sul, Brazil)

Professor
Robert Platt
(Department of Epidemiology, Biostatistics, and Occupational Health (EBOH), McGill University, Canada)